Axa’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-293,853
| Closed | -$4.11M | – | 352 |
|
|
2025
Q2 | $4.11M | Buy |
293,853
+472
| +0.2% | +$6.64K | 0.01% | 603 |
|
|
2025
Q1 | $3.99M | Sell |
293,381
-374
| -0.1% | -$7.17K | 0.01% | 599 |
|
|
2024
Q4 | $5.99M | Sell |
293,755
-51,128
| -15% | -$1.31M | 0.02% | 494 |
|
|
2024
Q3 | $10M | Buy |
344,883
+98
| +0% | +$2.43K | 0.03% | 393 |
|
|
2024
Q2 | $8.01M | Sell |
344,785
-16,023
| -4% | -$308K | 0.02% | 430 |
|
|
2024
Q1 | $7.4M | Buy |
360,808
+213
| +0.1% | +$4K | 0.02% | 469 |
|
|
2023
Q4 | $7.74M | Buy |
360,595
+6,066
| +2% | +$120K | 0.03% | 451 |
|
|
2023
Q3 | $7.31M | Sell |
354,529
-3,853
| -1% | -$97.7K | 0.03% | 452 |
|
|
2023
Q2 | $10.6M | Buy |
358,382
+69,140
| +24% | +$1.94M | 0.04% | 397 |
|
|
2023
Q1 | $6.66M | Sell |
289,242
-678
| -0.2% | -$18.7K | 0.02% | 492 |
|
|
2022
Q4 | $8.06M | Buy |
289,920
+41,148
| +17% | +$1.22M | 0.03% | 483 |
|
|
2022
Q3 | $7.63M | Buy |
248,772
+1,081
| +0.4% | +$35.1K | 0.03% | 487 |
|
|
2022
Q2 | $7.29M | Buy |
247,691
+47,123
| +23% | +$1.23M | 0.03% | 493 |
|
|
2022
Q1 | $6.45M | Sell |
200,568
-19,498
| -9% | -$671K | 0.02% | 579 |
|
|
2021
Q4 | $9.81M | Buy |
220,066
+18,486
| +9% | +$876K | 0.03% | 494 |
|
|
2021
Q3 | $10.2M | Buy |
201,580
+18,880
| +10% | +$1.06M | 0.03% | 492 |
|
|
2021
Q2 | $14.3M | Buy |
182,700
+5,722
| +3% | +$354K | 0.04% | 434 |
|
|
2021
Q1 | $10.1M | Buy |
176,978
+18,788
| +12% | +$1.26M | 0.03% | 513 |
|
|
2020
Q4 | $13.3M | Sell |
158,190
-64,881
| -29% | -$3.92M | 0.04% | 428 |
|
|
2020
Q3 | $7.99M | Sell |
223,071
-2,119
| -0.9% | -$63.8K | 0.03% | 522 |
|
|
2020
Q2 | $5.45M | Buy |
225,190
+37,228
| +20% | +$875K | 0.02% | 592 |
|
|
2020
Q1 | $3.29M | Buy |
+187,962
| New | +$3.92M | 0.02% | 629 |
|
Other funds holding DNLI
